It has been validated that LINC00460 functions as a competing endogenous RNA (ceRNA) in co-expression and promotes the malignant development of multiple cancers, including prostate cancer (37), skin cancer (38), hepatocellular cancer (39), colorectal cancer (40) and so on, except for RCC. This evidence concerns the gene LINC00460 and skin cancer.